Work

Clinical utility and cost-effectiveness of a molecular biomarker for immune checkpoint inhibitor response monitoring and treatment decisions.

Year: 2025

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e23338

Authors: Zachary Rivers, Akash Mitra, Victoria L. Chiou, Halla Nimeiri, Sheetal Mehta Kircher, David D. Stenehjem, Rotem Ben-Shachar, Charu Aggarwal

Institutions: Tempus Labs (United States), Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, University of Minnesota, University of Minnesota, Duluth, Abramson Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410814542

FWCI:

Cites:

Cited by:

Related to: 10